These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 12407573)

  • 1. Course and outcome of hepatitis C.
    Hoofnagle JH
    Hepatology; 2002 Nov; 36(5 Suppl 1):S21-9. PubMed ID: 12407573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
    Chu CM; Sheen IS; Liaw YF
    Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical picture and evolution of hepatitis C].
    Marcellin P; Erlinger S
    Bull Acad Natl Med; 1996; 180(6):1267-76; discussion 1276-8. PubMed ID: 8991608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular biology of HCV infection and hepatitis.
    Tang H; Grisé H
    Clin Sci (Lond); 2009 Jun; 117(2):49-65. PubMed ID: 19515018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Virology of hepatitis C virus].
    Hofmann H
    Wien Med Wochenschr; 2000; 150(23-24):463-6. PubMed ID: 11205175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of acute symptomatic hepatitis type C.
    Wawrzynowicz-Syczewska M; Kubicka J; Lewandowski Z; Boroń-Kaczmarska A; Radkowski M
    Infection; 2004 Jun; 32(3):138-43. PubMed ID: 15188072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
    Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
    J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribavirin in the treatment of hepatitis C.
    Abonyi ME; Lakatos PL
    Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications.
    Lee CM; Lu SN; Hung CH; Tung WC; Wang JH; Tung HD; Chen CH; Hu TH; Changchien CS; Chen WJ
    Trans R Soc Trop Med Hyg; 2006 Aug; 100(8):767-74. PubMed ID: 16443243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C--clinical profile.
    Bhandari B; Pal A
    J Indian Med Assoc; 2007 Aug; 105(8):453-4, 456, 465. PubMed ID: 18236909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis C, awakening of a giant].
    van Hattum J
    Ned Tijdschr Geneeskd; 1996 Jan; 140(3):119-24. PubMed ID: 8618627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection acquired in childhood.
    Camarero C; Ramos N; Moreno A; Asensio A; Mateos ML; Roldan B
    Eur J Pediatr; 2008 Feb; 167(2):219-24. PubMed ID: 17464514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute/recent HCV infection. Clinical course, viral replication kunetic and disease outcome.
    Tsertsvadze T; Sharvadze L; Dzigua L; Dolmazashvili E; Nelson KE
    Georgian Med News; 2008 Dec; (165):43-9. PubMed ID: 19124916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis.
    Lemos LB; Perez RM; Matos CA; Silva IS; Silva AE; Ferraz ML
    J Clin Gastroenterol; 2008 Feb; 42(2):208-11. PubMed ID: 18209594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.